Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Says AI Regulations May Require More Congressional Authorities

Mar 23 2020

Behtany Hills and Bakul Patel — Life science attorney Bethany Hills and the FDA's Bakul Patel at the 2019 World Medical Innovation Forum in Boston • Source: Ferdous Al-Faruque

Related Content

If You Build It, They Will Come: FDAer Says Pre-Cert Program Getting Global Attention, AI Paper Just the Start

Apr 11 2019

Rise Of The Machines: FDA Artificial Intelligence Guidance Is Coming

Apr 02 2019

Podcast: US FDA’s Artificial Intelligence Guidance May Need Congress And Is At Least A Year Away, Expert Says

Jul 29 2019

'Excellence' In Health-Software Design: US FDA Taps Nine Firms To Figure Out What That Means

Sep 26 2017

Podcast: Q&A – FDA Device Center Director Lays Out 2020 Priorities

Mar 05 2020

Additional Topics

United States Artificial Intelligence FDA Regulation Digital Health Emerging Markets Innovation Guidance Documents Diagnostic Imaging Medical Device

More from AI

More from Digital Technologies

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window